Calcineurin is a Ca2+/calmodulin activated phosphatase that couples Ca 2+ pulses to gene transcription. Importantly, it is the target for two of the most widely used immunosuppressants, cyclosporin A and FK506, both of which inhibit bone formation and cause skeletal loss. We now find that deletion of the alpha isoform of calcineurin A impairs, by -50%, the ability of hematopoetic stem cell precursors to form osteoclasts in response to RANK-L, a key osteoclastogenic cytokine. This effect is mimicked by both cyclosporin A and FK506, suggesting that calcineurin is downstream of RANK-L. We also find that RANK-L stimulates the expression and nuclear import of calcineurin's primary substrate, NFATc1. Likewise, Ca2+ triggers NFATc1 import, stimulates osteoclast formation, and inhibits the transcription of an anti-osteoclastogenic gene, CD38. Dominant-negative NFAT attenuates, while constitutively active NFAT enhances osteoclast precursor differentiation. However, apart from NFATc1, calcineurin also binds to and dephosphorylates the transcription inhibitor, lkB, likely as a means to prevent unrestricted osteoclastogenesis. Thus, our central hypothesis is that calcineurin and NFATc1 are both required for the osteoclastogenesis induced by RANKL and Ca2+ that is in turn regulated by the concomitant dephosphorylation of IkB.
Specific Aim 1 will determine whether calcineurin is necessary for RANK-L-induced osteoclast formation through gain- and loss-of-function experiments involving (a) transduction of constitutively active and dominant negative calcineurin mutants as TAT fusion proteins, (b) stably transfecting osteoclast precursors with isoform-specific calcineurin snRNAs, and (c) rescuing the defective osteoclastogenesis in Aa-/- stem cells.
Specific Aim 2 will examine the relative contributions of NFATc1 and IkBa in modulating RANK-L-induced osteoclastogenesis.
Specific Aim 3 will investigate whether the effects of Ca2+ on osteoclast formation and target gene expression require calcineurin and NFATc1. For both the latter aims, we will combine cross-linking, co-immunoprecipitation, dephosphorylation, and nuclear translocation assays with constitutively active and dominant-negative NFAT transduction in vitro.
In Specific Aim 2, the two mutants will also be over-expressed in osteoclasts in transgenic mice and effects on the skeleton examined by bone densitometry, micro-computerized tomography, histomorphometry, and remodeling marker measurements. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK070526-11
Application #
7110968
Study Section
Skeletal Biology Structure and Regeneration Study Section (SBSR)
Program Officer
Malozowski, Saul N
Project Start
1997-01-15
Project End
2008-05-31
Budget Start
2006-06-01
Budget End
2007-05-31
Support Year
11
Fiscal Year
2006
Total Cost
$358,504
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Baliram, R; Chow, A; Huber, A K et al. (2013) Thyroid and bone: macrophage-derived TSH-? splice variant increases murine osteoblastogenesis. Endocrinology 154:4919-26
Zhu, Ling-Ling; Tourkova, Irina; Yuen, Tony et al. (2012) Blocking FSH action attenuates osteoclastogenesis. Biochem Biophys Res Commun 422:54-8
Baliram, Ramkumarie; Sun, Li; Cao, Jay et al. (2012) Hyperthyroid-associated osteoporosis is exacerbated by the loss of TSH signaling. J Clin Invest 122:3737-41
Baliram, Ramkumarie; Latif, Rauf; Berkowitz, Joshua et al. (2011) Thyroid-stimulating hormone induces a Wnt-dependent, feed-forward loop for osteoblastogenesis in embryonic stem cell cultures. Proc Natl Acad Sci U S A 108:16277-82
Leong, Daniel J; Li, Yong H; Gu, Xiang I et al. (2011) Physiological loading of joints prevents cartilage degradation through CITED2. FASEB J 25:182-91
Mistry, Pramod K; Liu, Jun; Yang, Mei et al. (2010) Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage. Proc Natl Acad Sci U S A 107:19473-8
Arora, Shitij; Agrawal, Manasi; Sun, Li et al. (2010) HIV and bone loss. Curr Osteoporos Rep 8:219-26
Sun, Li; Zhang, Zhiyuan; Zhu, Ling-Ling et al. (2010) Further evidence for direct pro-resorptive actions of FSH. Biochem Biophys Res Commun 394:6-11
Zaidi, Mone; Sun, Li; Robinson, Lisa J et al. (2010) ACTH protects against glucocorticoid-induced osteonecrosis of bone. Proc Natl Acad Sci U S A 107:8782-7
Iqbal, Jameel; Davies, Terry F; Sun, Li et al. (2009) Skeletal morphofunctional considerations and the pituitary-thyroid axis. Front Biosci (Schol Ed) 1:92-107

Showing the most recent 10 out of 38 publications